Free Trial
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free MDCXW Stock Alerts

Medicus Pharma (MDCXW) Competitors

$0.30 0.00 (-0.33%)
As of 10/9/2026 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

MDCXW vs. SXTPW, BFRIW, CALA, CINGW, and CLVR

Should you buy Medicus Pharma stock or one of its competitors? Medicus Pharma's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Calithera Biosciences (CALA), Cingulate (CINGW), and Clever Leaves (CLVR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Medicus Pharma compare to 60 Degrees Pharmaceuticals?

Medicus Pharma (NASDAQ:MDCXW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

In the previous week, 60 Degrees Pharmaceuticals had 3 more articles in the media than Medicus Pharma. MarketBeat recorded 4 mentions for 60 Degrees Pharmaceuticals and 1 mentions for Medicus Pharma. Medicus Pharma's average media sentiment score of 1.82 beat 60 Degrees Pharmaceuticals' score of 1.19 indicating that Medicus Pharma is being referred to more favorably in the media.

Company Overall Sentiment
Medicus Pharma Very Positive
60 Degrees Pharmaceuticals Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicus PharmaN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Medicus PharmaN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats Medicus Pharma on 2 of the 3 factors compared between the two stocks.

How does Medicus Pharma compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Medicus Pharma (NASDAQ:MDCXW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
Medicus PharmaN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Medicus Pharma N/A N/A N/A

In the previous week, Biofrontera had 1 more articles in the media than Medicus Pharma. MarketBeat recorded 2 mentions for Biofrontera and 1 mentions for Medicus Pharma. Medicus Pharma's average media sentiment score of 1.82 beat Biofrontera's score of 0.91 indicating that Medicus Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Biofrontera Positive
Medicus Pharma Very Positive

Summary

Biofrontera beats Medicus Pharma on 2 of the 3 factors compared between the two stocks.

How does Medicus Pharma compare to Calithera Biosciences?

Calithera Biosciences (NASDAQ:CALA) and Medicus Pharma (NASDAQ:MDCXW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

In the previous week, Calithera Biosciences and Calithera Biosciences both had 1 articles in the media. Medicus Pharma's average media sentiment score of 1.82 beat Calithera Biosciences' score of 0.67 indicating that Medicus Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Calithera Biosciences Positive
Medicus Pharma Very Positive

Company Net Margins Return on Equity Return on Assets
Calithera BiosciencesN/A N/A N/A
Medicus Pharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Calithera BiosciencesN/AN/A-$39.65MN/AN/A
Medicus PharmaN/AN/AN/AN/AN/A

Summary

Medicus Pharma beats Calithera Biosciences on 1 of the 1 factors compared between the two stocks.

How does Medicus Pharma compare to Cingulate?

Cingulate (NASDAQ:CINGW) and Medicus Pharma (NASDAQ:MDCXW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

In the previous week, Cingulate had 1 more articles in the media than Medicus Pharma. MarketBeat recorded 2 mentions for Cingulate and 1 mentions for Medicus Pharma. Medicus Pharma's average media sentiment score of 1.82 beat Cingulate's score of 1.41 indicating that Medicus Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Cingulate Positive
Medicus Pharma Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Medicus PharmaN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Medicus Pharma N/A N/A N/A

Summary

Cingulate and Medicus Pharma tied by winning 1 of the 2 factors compared between the two stocks.

How does Medicus Pharma compare to Clever Leaves?

Medicus Pharma (NASDAQ:MDCXW) and Clever Leaves (NASDAQ:CLVR) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

In the previous week, Medicus Pharma had 1 more articles in the media than Clever Leaves. MarketBeat recorded 1 mentions for Medicus Pharma and 0 mentions for Clever Leaves. Medicus Pharma's average media sentiment score of 1.82 beat Clever Leaves' score of 0.00 indicating that Medicus Pharma is being referred to more favorably in the media.

Company Overall Sentiment
Medicus Pharma Very Positive
Clever Leaves Neutral

Company Net Margins Return on Equity Return on Assets
Medicus PharmaN/A N/A N/A
Clever Leaves N/A N/A N/A

6.9% of Clever Leaves shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Medicus Pharma has higher earnings, but lower revenue than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicus PharmaN/AN/AN/AN/AN/A
Clever Leaves$17.42M0.00-$17.90M-$7.56N/A

Summary

Clever Leaves beats Medicus Pharma on 3 of the 5 factors compared between the two stocks.

Get Medicus Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDCXW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDCXW vs. The Competition

Export
MetricMedicus PharmaPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$12.43B$7.26B$13.29B
Dividend YieldN/A2.63%2.52%22.58%
P/E RatioN/A800.13275.2826.14
Price / SalesN/A752.39586.2687.63
Price / CashN/A15.2827.3036.12
Price / BookN/A9.1510.826.16
Net IncomeN/A$2.84B$3.50B$381.12M
7 Day PerformanceN/A-0.94%-0.89%-1.40%
1 Month Performance-27.33%-3.67%-4.02%-3.35%
1 Year Performance-74.89%-3.97%7.13%1.49%

Medicus Pharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDCXW
Medicus Pharma
N/A$0.23
-24.7%		N/A-74.9%$0.00N/AN/A16
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-42.9%$0.00$1.11MN/A3
BFRIW
Biofrontera
N/A$0.01
-1.3%		N/A-94.5%$0.00$46.18MN/A94
CALA
Calithera Biosciences
N/A$0.00
flat		N/AN/A$0.00N/AN/A60
CINGW
Cingulate
N/A$0.00
-35.0%		N/AN/A$0.00N/AN/A14

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:MDCXW) was last updated on 10/11/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel